Pacific Biosciences of California Aktie
0,86
EUR
-0,04
EUR
-3,99
%
0,99
USD
+0,03
USD
+2,93
%
Werbung
Pacific Biosciences of California Aktie Analyse
19.10.18 | Pacific Biosciences of California Outperform | Cowen and Company, LLC | |
03.11.16 | Pacific Biosciences of California Buy | Cantor Fitzgerald | |
15.04.16 | Pacific Biosciences of California Overweight | First Analysis Securities | |
04.02.15 | Pacific Biosciences of California Buy | Maxim Group |
Werbung
Werbung